Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Sony Group Corp (SONY) vs Tenet Healthcare Corporation (THC) Price & Performance

Sony Group CorpTrade
Tenet Healthcare CorporationTrade

Price performance (Past 24H)

Key statistics

Sony Group Corp vs Tenet Healthcare Corporation — how do they compare? Sony Group Corp trades at $23.47 (market cap $139.99B), while Tenet Healthcare Corporation trades at $260.39 (market cap $20.93B). The key difference: Sony Group Corp is far larger — about 6.7× Tenet Healthcare Corporation's market cap, and Sony Group Corp pays a 0.67% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals.

SONYTHC
Market Cap
$139.99B$20.93B
Sector
TechnologyHealth
52-Week High
$30.26$262.63
52-Week Low
$19.32$161.37
Enterprise Value
$137.89B$32.01B
Dividend Yield
0.67%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Sony Group Corp

Sony stock trades at $23.46, up 1.56% with bullish technical indicators and strong analyst support. The company shows solid revenue growth with $12.96T in 2025 sales and improved profitability, though 2026 projections indicate potential margin pressure. Recent catalysts include the record-breaking Spider-Man film performance and a $6.3B joint venture with TSMC for next-generation image sensors, positioning Sony for continued entertainment and technology leadership.

Sony presents a compelling investment case with strong entertainment franchises and technological innovation, though investors should monitor execution risks in the gaming transition and potential margin compression. Wall Street remains overwhelmingly bullish with 11 buy ratings and a 29.75% upside potential, but the stock faces challenges from currency volatility and competitive pressures in key markets.

Tenet Healthcare Corporation

Tenet Healthcare (THC) trades at $262.13, up 2.14% with strong technical momentum and bullish analyst sentiment. The stock shows robust fundamentals with Q2 2026 EPS beating estimates at $6.12 versus $4.26 expected, while valuation metrics remain attractive with P/E of 10.05 and EV/EBITDA of 5.74. Recent institutional buying and positive earnings revisions support the upward trend.

Outlook remains positive with consensus price target of $281.44 offering 7.4% upside potential. Key risks include healthcare policy headwinds and competitive pressures, but strong ambulatory growth and expense management provide fundamental support. The stock presents a compelling value-growth combination for investors seeking healthcare exposure.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Sony Group Corp

Sony Group is a conglomerate with consumer electronics roots, which not only designs, develops, produces, and sells electronic equipment and devices, but also is engaged in content businesses, such as console and mobile games, music, and movies. Sony is a global top company of CMOS image sensors, game consoles, professional broadcasting cameras, and music publishing, and is one of the top players on digital cameras, wireless earphones, recorded music, movies, and so on. Sony's business portfolio is well diversified with six major business segments. The company fully consolidated Sony Financial in September 2020, which provides life and non-life insurance, banking, and other financial services.

Read more on SONY

About Tenet Healthcare Corporation

Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.

Read more on THC